Literature DB >> 2890095

Antiproliferative and cytotoxic effects of newly discovered halogenated coral prostanoids from the Japanese stolonifer Clavularia viridis on human myeloid leukemia cells in culture.

A Honda1, Y Mori, K Iguchi, Y Yamada.   

Abstract

The antiproliferative and cytotoxic activities of newly discovered halogenated coral prostanoids (chlorovulone, bromovulone, and iodovulone) from the Japanese stolonifer Clavularia viridis and their related compounds were determined in HL-60 cells in culture. The order of antiproliferative and cytotoxic activities of naturally occurring marine prostanoids against HL-60 cells was chlorovulone I greater than bromovulone I = iodovulone I greater than clavulone I or II greater than prostaglandin A2. The IC50 (concentrations required to inhibit cell growth by 50%) value (0.03 microM (0.01 microgram/ml)) and cytotoxic effects (greater than 0.3 microM (0.1 microgram/ml)) of chlorovulone I were about 200 and 100 times stronger than those of prostaglandin A2, respectively, on the molar basis. From our data on the structure-activity relationship of the halogenated coral prostanoids and the related compounds, we elucidated that 1) the alkylidencyclopentenone structure in these prostanoids was essential for the antiproliferative and cytotoxic activities against HL-60 cells and the introduction of halogen function at C-10 position in the structure enhanced the activities (C1 = F greater than Br = I greater than H); 2) the stereospecificity of the 12-hydroxyl group in the chlorovulone molecule was not required for the activities; 3) the presence of dienone (C5-6 and C7-8) in the structure potentiated the activities. Bivariate DNA/bromodeoxyuridine analysis with a flow cytometer showed that chlorovulone I transiently arrested the cell cycle progression from G1 to S after 24-hr exposure to the nontoxic concentrations (0.03 and 0.09 microM) and caused the lasting blockade of leukemia cells in G1 at the cytotoxic concentration. These results suggest that these coral prostanoids and related compounds may be a promising antileukemic agent.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890095

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  Localization of clavulones, prostanoids with antitumor activity, within the Okinawan soft coral Clavularia viridis (Alcyonacea, Clavulariidae): preparation of a high-purity Symbiodinium fraction using a protease and a detergent.

Authors:  Naoko Hashimoto; Shoko Fujiwara; Kinzo Watanabe; Kazuo Iguchi; Mikio Tsuzuki
Journal:  Lipids       Date:  2003-09       Impact factor: 1.880

2.  Induction of Apoptosis in Human Leukemia Cell Line (HL60) by Animal's Venom Derived Peptides (ICD-85).

Authors:  Abbas Zare Mirakabadi; Zahra Shahramyar; Hasan Morovvati; Mohsen Lotfi; Ali Nouri
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

3.  Biochemical warfare on the reef: the role of glutathione transferases in consumer tolerance of dietary prostaglandins.

Authors:  Kristen E Whalen; Amy L Lane; Julia Kubanek; Mark E Hahn
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

4.  Extracts from Cladiella australis, Clavularia viridis and Klyxum simplex (soft corals) are capable of inhibiting the growth of human oral squamous cell carcinoma cells.

Authors:  Chia-Hua Liang; Guey-Horng Wang; Chih-Chuang Liaw; Mei-Feng Lee; Shih-Hao Wang; Da-Long Cheng; Tzung-Han Chou
Journal:  Mar Drugs       Date:  2008-11-03       Impact factor: 5.118

Review 5.  Cytotoxic and cytolytic cnidarian venoms. A review on health implications and possible therapeutic applications.

Authors:  Gian Luigi Mariottini; Luigi Pane
Journal:  Toxins (Basel)       Date:  2013-12-27       Impact factor: 4.546

6.  Metabolomic study of soft corals from the Colombian Caribbean: PSYCHE and 1H-NMR comparative analysis.

Authors:  Liliana Santacruz; Diana X Hurtado; Roisin Doohan; Olivier P Thomas; Mónica Puyana; Edisson Tello
Journal:  Sci Rep       Date:  2020-03-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.